The Latest Advances in CAR T-Cell Therapy for Refractory and Relapsed Lymphomas and Leukemias

1.0 AMA PRA Category 1 Credit(s)™
1.0 CNE Contact Hour
1.0 Attendance Credit


CME, CNE, Other

Expires: 09/12/18

@WARNING@<strong>Warning!</strong> This program has expired

Click here to access the activity in order to claim credit.